""

Neuroendocrine tumors

Recruiting after consultation
Open recruiting

Neoadjuvant Therapy

There are currently no studies available

Adjuvant Therapy

There are currently no studies available

Metastatic Disease: First-Line-Therapy

Title: CABONEN - A Phase II Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3
Phase: II
Contact: Elisabeth Lawrence / Kontaktperson
Clinical Investigator: Dr. med. Leonidas Apostolidis
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT04524208
EudraCT-Number: Siehe EU klinisches Studienregister 2020-002541-41

Metastatic Disease: Follow-Up Treatment

Title: CABONEN - A Phase II Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3
Phase: II
Contact: Elisabeth Lawrence / Kontaktperson
Clinical Investigator: Dr. med. Leonidas Apostolidis
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT04524208
EudraCT-Number: Siehe EU klinisches Studienregister 2020-002541-41

Surgical Study

There are currently no studies available

Radiotherapy Study

There are currently no studies available

Other study

There are currently no studies available